Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics

A Chamoli, AS Gosavi, UP Shirwadkar, KV Wangdale… - Oral oncology, 2021 - Elsevier
Oral cavity squamous cell carcinoma (OCSCC) is the most common malignancy of the oral
cavity. The substantial risk factors for OCSCC are the consumption of tobacco products …

The molecular biology of head and neck cancer

CR Leemans, BJM Braakhuis, RH Brakenhoff - Nature reviews cancer, 2011 - nature.com
Head and neck squamous cell carcinomas (HNSCCs) are caused by tobacco and alcohol
consumption and by infection with high-risk types of human papillomavirus (HPV). Tumours …

Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers

VWY Lui, ML Hedberg, H Li, BS Vangara, K Pendleton… - Cancer discovery, 2013 - AACR
Genomic findings underscore the heterogeneity of head and neck squamous cell carcinoma
(HNSCC). Identification of mutations that predict therapeutic response would be a major …

PIK3CA in cancer: The past 30 years

R Arafeh, Y Samuels - Seminars in cancer biology, 2019 - Elsevier
Almost thirty years ago, PI3K was discovered as a lipid kinase associated with certain
oncoproteins. The first decade of research on PI3K saw the identification, purification and …

[HTML][HTML] Proliferation and apoptosis pathways and factors in oral squamous cell carcinoma

S He, R Chakraborty, S Ranganathan - International journal of molecular …, 2022 - mdpi.com
Oral cancer is the most common form of head and neck squamous cell carcinoma (HNSCC)
and most frequently presents as oral squamous cell carcinoma (OSCC), which is associated …

Oncogenic mutations of PIK3CA in human cancers

Y Samuels, T Waldman - Phosphoinositide 3-kinase in Health and …, 2011 - Springer
The involvement of the PIK3CA gene product p110α, the catalytic subunit of
phosphatidylinositol 3-kinase (PI3K), in human cancer has been suggested for over 15 …

[HTML][HTML] FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

LC Kompier, I Lurkin, MNM van der Aa, BWG van Rhijn… - PloS one, 2010 - journals.plos.org
Background Fifty percent of patients with muscle–invasive bladder cancer (MI-BC) die from
their disease and current chemotherapy treatment only marginally increases survival. Novel …

Dysregulated molecular networks in head and neck carcinogenesis

AA Molinolo, P Amornphimoltham, CH Squarize… - Oral oncology, 2009 - Elsevier
Multiple genetic and epigenetic events, including the aberrant expression and function of
molecules regulating cell signaling, growth, survival, motility, angiogenesis, and cell cycle …

The Tumor Suppressive MicroRNA miR-218 Targets the mTOR Component Rictor and Inhibits AKT Phosphorylation in Oral Cancer

A Uesugi, K Kozaki, T Tsuruta, M Furuta, K Morita… - Cancer research, 2011 - AACR
The incidence of oral squamous cell carcinoma (OSCC) is rising rapidly in developed
countries, posing a growing challenge due to the poor management of this type of …

The PI 3 K/A kt/m TOR axis in head and neck cancer: functions, aberrations, cross‐talk, and therapies

R Vander Broek, S Mohan, DF Eytan, Z Chen… - Oral …, 2015 - Wiley Online Library
Head and neck squamous cell carcinoma (HNSCC) is one of the most morbid, mortal, and
genetically diverse malignancies. Although HNSCC is heterogeneous in nature, alterations …